Obesidad, desregulación estrogénica y riesgo de cáncer de mama en mujeres posmenopáusicas: revisión sistemática con síntesis narrativa crítica

Amadou, A., Freisling, H., Sedlmeier, A. M., Bohmann, P., Fontvieille, E., Weber, A., Konzok, J., Stein, M. J., Peruchet-Noray, L., Jansana, A., Noh, H., His, M., Gan, Q., Baurecht, H., & Fervers, B. (2024). Multi-trait body shape phenotypes and breast cancer risk in postmenopausal women: A causal mediation analysis in the UK Biobank Cohort. Journal of Epidemiology and Global Health, 14(2), 420-432. https://doi.org/10.1007/s44197-024-00226-4

Aromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom, P. (2015). Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach. International Journal of Evidence-Based Healthcare, 13(3), 132-140. https:/doi.org/10.1097/XEB.0000000000000055

Arthur, R. S., Xue, X., Kamensky, V., Chlebowski, R. T., Simon, M., Luo, J., Shadyab, A. H., Neuhouser, M. L., Banack, H., Ho, G. Y. F., Lane, D. S., Pan, K., Reding, K. W., Wassertheil-Smoller, S., Dannenberg, A. J., & Rohan, T. E. (2020). The association between DXA-derived body fat measures and breast cancer risk among postmenopausal women in the Women’s Health Initiative. Cancer Medicine, 9(4), 1581-1599. https://doi.org/10.1002/cam4.2690

Barker, T. H., Habibi, N., Aromataris, E., Stone, J. C., Leonardi-Bee, J., Sears, K., Hasanoff, S., Klugar, M., Tufanaru, C., Moola, S., & Munn, Z. (2024). The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evidence Synthesis, 22(3), 378-388. https://doi.org/10.11124/JBIES-23-00268

Barker, T. H., Hasanoff, S., Aromataris, E., Stone, J. C., Leonardi-Bee, J., Sears, K., Habibi, N., Klugar, M., Tufanaru, C., Moola, S., Liu, X. L., & Munn, Z. (2025). The revised JBI critical appraisal tool for the assessment of risk of bias for cohort studies. JBI Evidence Synthesis, 23(3), 441-453. https://doi.org/10.11124/JBIES-24-00103

Barker, T. H., Hasanoff, S., Aromataris, E., Stone, J. C., Leonardi-Bee, J., Sears, K., Klugar, M., Tufanaru, C., Moola, S., Liu, X. L., & Munn, Z. (2026). The revised JBI critical appraisal tool for the assessment of risk of bias for analytical cross-sectional studies. JBI Evidence Synthesis, 24(3), 401-408. https://doi.org/10.11124/JBIES-24-00523

Barker, T. H., Stone, J. C., Sears, K., Klugar, M., Tufanaru, C., Leonardi-Bee, J., Aromataris, E., & Munn, Z. (2023). The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evidence Synthesis, 21(3), 494-506. https://doi.org/10.11124/JBIES-22-00430

Baş, D., Arıbal, M. E., Vardareli, E., Sönmez, Ö., Oyan, B., Özden, B. Ç., & Sonkaya, A. (2023). Validation of bioelectrical impedance analysis in the evaluation of body composition in pa-tients with breast cancer. Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition, 38(4), 817-829. https://doi.org/10.1002/ncp.10947

Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229-263. https://doi.org/10.3322/caac.21834

Brown, K. A. (2021). Metabolic pathways in obesity-related breast cancer. Nature Reviews. Endocrinology, 17(6), 350-363. https://doi.org/10.1038/s41574-021-00487-0

Cao, Y., Xia, B., Zhang, Z., Hu, D., Huang, X., Yuan, J., & Li, F. (2023). Association of body fat distribution and risk of breast cancer in pre- and postmenopausal women. Obesity Facts, 16(4), 356-363. https://doi.org/10.1159/000529834

Chlebowski, R. T., Aragaki, A. K., Pan, K., Simon, M. S., Neuhouser, M. L., Haque, R., Rohan, T. E., Wactawski-Wende, J., Orchard, T. S., Mortimer, J. E., Lane, D., Kaunitz, A. M., Desai, P., Wild, R. A., Barac, A., & Manson, J. E. (2024). Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health Initiative. Cancer, 130(18), 3147-3156. https://doi.org/10.1002/cncr.35318

Cho, B. A., Iyengar, N. M., Zhou, X. K., Morrow, M., Giri, D. D., Verma, A., Elemento, O., Pollak, M., & Dannenberg, A. J. (2021). Blood biomarkers reflect the effects of obesity and inflammation on the human breast transcriptome. Carcinogenesis, 42(10), 1281-1292. https://doi.org/10.1093/carcin/bgab066

Chow, H. H. S., Garland, L. L., Heckman-Stoddard, B. M., Hsu, C. H., Butler, V. D., Cordova, C. A., Chew, W. M., & Cornelison, T. L. (2014). A pilot clinical study of resveratrol in post-menopausal women with high body mass index: Effects on systemic sex steroid hormones. Journal of Translational Medicine, 12(1), 223. https://doi.org/10.1186/s12967-014-0223-0

Dashti, S. G., Simpson, J. A., Viallon, V., Karahalios, A., Moreno-Betancur, M., Brasky, T., Pan, K., Rohan, T. E., Shadyab, A. H., Thomson, C. A., Wild, R. A., Wassertheil-Smoller, S., Ho, G. Y. F., Strickler, H. D., English, D. R., & Gunter, M. J. (2022). Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol. Cancer Medicine, 11(4), 1145-1159. https://doi.org/10.1002/cam4.4434

Dehesh, T., Fadaghi, S., Seyedi, M., Abolhadi, E., Ilaghi, M., Shams, P., Ajam, F., Mosleh-Shirazi, M. A., & Dehesh, P. (2023). The relation between obesity and breast cancer risk in women by

considering menstruation status and geographical variations: A systematic review and meta-analysis. BMC Women’s Health, 23(1), 392. https://doi.org/10.1186/s12905-023-02543-5

Diao, S., Wu, X., Zhang, X., Hao, Y., Xu, B., Li, X., Tian, L., Miao, Y., Zhao, X., Ye, F., & Li, J. (2021). Obesity-related proteins score as a potential marker of breast cancer risk. Scientific Reports, 11(1), 8230. https://doi.org/10.1038/s41598-021-87583-3

Dimauro, I., Grazioli, E., Antinozzi, C., Duranti, G., Arminio, A., Mancini, A., Greco, E. A., Caporossi, D., Parisi, A., & Di Luigi, L. (2021). Estrogen-receptor-positive breast cancer in postmenopausal women: The role of body composition and physical exercise. International Journal of Environmental Research and Public Health, 18(18), 9834. https://doi.org/10.3390/ijerph18189834

Fabian, C. J., Kimler, B. F., & Hursting, S. D. (2015). Omega-3 fatty acids for breast cancer prevention and survivorship. Breast Cancer Research, 17(1), 62. https://doi.org/10.1186/s13058-015-0571-6

Fadhila, S. N., Murti, B., & Widyaningsih, V. (2021). Overweight and obesity as risk factors of breast cancer in premenopausal and postmenopausal women: Meta-analysis. Journal of Maternal and Child Health, 6(6), 678-689. https://doi.org/10.26911/thejmch.2021.06.06.06

Gathirua-Mwangi, W. G., Palmer, J. R., Champion, V., Castro-Webb, N., Stokes, A. C., Adams-Campbell, L., Marley, A. R., Forman, M. R., Rosenberg, L., & Bertrand, K. A. (2022). Maximum and time-dependent body mass index and breast cancer incidence among postmenopausal women in the Black Women's Health Study. American Journal of Epidemiology, 191(4), 646654. https://doi.org/10.1093/aje/kwac004

GBD 2023 Cancer Collaborators (2025). The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet, 406(10512), 1565-1586. https://doi.org/10.1016/S0140-6736(25)01635-6

Geczik, A. M., Falk, R. T., Xu, X., Ansong, D., Yarney, J., Wiafe-Addai, B., Edusei, L., Dedey, F., Vanderpuye, V., Titiloye, N., Adjei, E., Aitpillah, F., Osei-Bonsu, E., Oppong, J., Biritwum, R., Nyarko, K., Wiafe, S., Awuah, B., Clegg-Lamptey, J. N., …, & Trabert, B. (2022). Measured body size and serum estrogen metabolism in postmenopausal women: The Ghana Breast Health Study. Breast Cancer Research: BCR, 24(1), 9. https://doi.org/10.1186/s13058-022-01500-8

Hao, Y., Xiao, J., Liang, Y., Wu, X., Zhang, H., Xiao, C., Zhang, L., Burgess, S., Wang, N., Zhao, X., Kraft, P., Li, J., & Jiang, X. (2023). Reassessing the causal role of obesity in breast cancer susceptibility: A comprehensive multivariable Mendelian randomization investigating the distribution and timing of exposure. International Journal of Epidemiology, 52(1), 58-70. https://doi.org/10.1093/ije/dyac143

Harborg, S., Cronin-Fenton, D., Jensen, M. R., Ahern, T. P., Ewertz, M., & Borgquist, S. (2023). Obesity and risk of recurrence in patients with breast cancer treated with aromatase inhibitors. JAMA Network Open, 6(10), e2337780. https://doi.org/10.1001/jamanetworkopen.2023.37780

Houghton, S. C., Eliassen, H., Tamimi, R. M., Willett, W. C., Rosner, B. A., & Hankinson, S. E. (2021). Central adiposity and subsequent risk of breast cancer by menopause status. Journal of the National Cancer Institute, 113(7), 900-908. https://doi.org/10.1093/jnci/djaa197

Ioannides, S. J., Barlow, P. L., Elwood, J. M., & Porter, D. (2014). Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review. Breast Cancer Research and Treatment, 147(2), 237-248. https://doi.org/10.1007/s10549-014-3091-7

Jung, S. Y., Scott, P. A., Papp, J. C., Sobel, E. M., Pellegrini, M., Yu, H., Han, S., & Zhang, Z. F. (2021). Genome-wide association analysis of proinflammatory cytokines and gene-lifestyle interaction for invasive breast cancer risk: The WHI dbGaP Study. Cancer Prevention Research (Philadelphia, Pa.), 14(1), 41-54. https://doi.org/10.1158/1940-6207.CAPR-20-0256

Kim, S., Campbell, J., Yoo, W., Taylor, J. A., & Sandler, D. P. (2023). Data from systemic levels of estrogens and PGE2 synthesis in relation to postmenopausal breast cancer risk. American Association for Cancer Research. [En línea]. Disponible en: https://doi.org/10.1158/1055-9965.c.6600537.v1. Fecha de consulta: 4 de noviembre de 2025.

Klintman, M., Rosendahl, A. H., Randeris, B., Eriksson, M., Czene, K., Hall, P., & Borgquist, S. (2022). Postmenopausal overweight and breast cancer risk; results from the KARMA cohort. Breast Cancer Research and Treatment, 196(1), 185-196. https://doi.org/10.1007/s10549-022-06664-7

Lee, J., Bae, S. J., Kim, H. K., Nam, S. J., Kim, H. J., Bae, S. Y., Park, H. Y., Ko, B. K., Park, J. H., Kwon, Y., Park, Y., Baek, S. H., Kook, Y., Kim, S., Lim, Y. A., Kang, H. J., Kim, D., Jeong, J., & Ahn, S. G. (2025). Body mass index and progesterone receptor in postmenopausal ER-positive/HER2-negative breast cancer: A nation-wide study in Korean breast cancer society and the multi-institutional cohort. Breast (Edinburgh, Scotland), 82, 104515. https://doi.org/10.1016/j.breast.2025.104515

Licznerska, B. E., Szaefer, H., Murias, M., Bartoszek, A., & Baer-Dubowska, W. (2013). Modulation of CYP19 expression by cabbage juices and their active components: indole-3-carbinol and 3,3’-diindolylmethene in human breast epithelial cell lines. European Journal of Nutrition, 52(5), 1483-1492. https://doi.org/10.1007/s00394-012-0455-9

Little, J., Higgins, J. P. T., Ioannidis, J. P. A., Moher, D., Gagnon, F., von-Elm, E., Khoury, M. J., Cohen, B., Davey-Smith, G., Grimshaw, J., Scheet, P., Gwinn, M., Williamson, R. E., Zou, G. Y., Hutchings, K., Johnson, C. Y., Tait, V., Wiens, M., Infante-Rivar, C., Golding, J., …, & Birkett, N. (2009). STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Medicine, 6(2), e22. https://doi.org/10.1371/journal.pmed.1000022

Llanos, A. A. M., Aremu, J. B., Cheng, T. D., Chen, W., Chekmareva, M. A., Cespedes Feliciano, E. M., Qin, B., Lin, Y., Omene, C., Khoury, T., Hong, C. C., Yao, S., Ambrosone, C. B., Bandera, E. V., & Demissie, K. (2022). Greater body fatness is associated with higher protein expression of LEPR in breast tumor tissues: A cross-sectional analysis in the Women's Circle of Health Study. Frontiers in Endocrinology, 13, 879164. https://doi.org/10.3389/fendo.2022.879164

Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021). Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers, 13(17), 4287. https://doi.org/10.3390/cancers13174287

Macis, D., Bellerba, F., Aristarco, V., Johansson, H., Guerrieri-Gonzaga, A., Lazzeroni, M., Sestak, I., Cuzick, J., De-Censi, A., Bonanni, B., & Gandini, S. (2024). A mediation analysis of obesity and adiponectin association with postmenopausal breast cancer risk: A nested cohort study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial. Nutrients, 16(13), 2098. https://doi.org/10.3390/nu16132098

Marino, P., Pepe, G., Basilicata, M. G., Vestuto, V. Marzocco, S., Autore, G., Procino, A., Gomez-Monterrey, I. M., Manfra, M., & Campiglia, P. (2023). Potential role of natural antioxidant products in oncological diseases. Antioxidants, 12(3), 704.

McArthur, A., Cooper, A., Edwards, D., Klugarova, J., Yan, H., Barber, B. V., Gregg, E. E., Weeks, L. E., & Jordan, Z. (2025). Textual evidence systematic reviews series paper 3: critical appraisal of evidence from narrative, opinion, and policy. JBI Evidence Synthesis, 23(5), 833-839. https://doi.org/10.11124/JBIES-24-00293

Mehmood, S., Yasin, A., Ahmad, I., Abiha Rabab, S., & Muhammad-Soomar, A. (2022). Relationship between obesity, menopausal status and breast cancer risks - A review: Obesity, menopausal status and breast cancer risks. Pakistan Journal of Health Sciences, 02-07. https://doi.org/10.54393/pjhs.v3i07.432

Mejia-Montilla, J., Reyna-Villasmil, N. y Reyna-Villasmil, E. (2022). Sobrepeso, obesidad y cáncer de mama. Revista de Obstetricia y Ginecología de Venezuela, 82(04), 499-510. https://doi.org/10.51288/00820414

Mérida-Ortega, Á., Rothenberg, S. J., Cebrián, M. E., & López-Carrillo, L. (2022). Breast cancer and urinary metal mixtures in Mexican women. Environmental Research, 210(112905), 112905. https://doi.org/10.1016/j.envres.2022.112905

Mérida-Ortega, Á., Gennings, C., Rothenberg, S. J., Cebrián, M. E., & López-Carrillo, L. (2023). Breast cancer molecular subtypes and supervised analysis of urinary metal mixtures in Mexican women. Exposure & Health, 15(4), 903-913. https://doi.org/10.1007/s12403-022-00532-x

Moola, S., Munn, Z., Tufanaru, C., Aromataris, E., Sears, K., Sfetc, R., Currie, M., Lisy, K., Qureshi, R., Mattis, P., & Mu, P. F. (2020). Chapter 7: Systematic reviews of etiology and risk. In JBI Manual for Evidence Synthesis. JBI.

Naaman, S. C., Shen, S., Zeytinoglu, M., & Iyengar, N. M. (2022). Obesity and breast cancer risk: The oncogenic implications of metabolic dysregulation. The Journal of Clinical Endocrinology and Metabolism, 107(8), 2154-2166. https://doi.org/10.1210/clinem/dgac241

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., …, & Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.), 372, n71. https://doi.org/10.1136/bmj.n71

Poorolajal, J., Heidarimoghis, F., Karami, M., Cheraghi, Z., Gohari-Ensaf, F., Shahbazi, F., Zareie, B., Ameri, P., & Sahraee, F. (2021). Factors for the primary prevention of breast cancer: A meta-analysis of prospective cohort studies. Journal of Research in Health Sciences, 21(3), e00520. https://doi.org/10.34172/jrhs.2021.57

Poschner, S., Maier-Salamon, A., Zehl, M., Wackerlig, J., Dobusch, D., Meshcheryakova, A., Mechtcheriakova, D., Thalhammer, T., Pachmann, B., & Jäger, W. (2018). Resveratrol inhibits key steps of steroid metabolism in a human estrogen-receptor positive breast cancer model: Impact on cellular proliferation. Frontiers in Pharmacology, 9, 742. https://doi.org/10.3389/fphar.2018.00742

Richardson, J., Loyola-Sanchez, A., Sinclair, S., Harris, J., Letts, L., MacIntyre, N. J., Wilkins, S., Burgos-Martinez, G., Wishart, L., McBay, C., & Martin-Ginis, K. (2014). Self-management interventions for chronic disease: A systematic scoping review. Clinical Rehabilitation, 28(11), 1067-1077. https://doi.org/10.1177/0269215514532478

Sampaio-de-Andrade, A., & Postorivo-Nauman, J. V. (2023). Obesity as a risk factor for developing breast cancer: systematic review. Salud Integral y Comunitaria, 1, 65. https://doi.org/10.62486/sic202365

Schindler, E. A., Takita, C., Collado-Mesa, F., Reis, I. M., Zhao, W., Yang, G. R., Acosta, L. G., & Hu, J. J. (2024). The interrelationship between obesity and race in breast cancer prognosis: A prospective cohort study. BMC Women's Health, 24(1), 312. https://doi.org/10.1186/s12905-024-03020-3

Shirdarreh, M. & Pezo, R. C. (2021). Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: A systematic review. Breast Cancer (Tokyo, Japan), 28(3), 755-764. https://doi.org/10.1007/s12282-020-01213-w

Silva, J. G., Cordeiro, G. G. S., Costa, F. B. S., Brock, Y. B., Andrade, A. B. de, Cardoso, H. M. V. L., Alves, J. R. A., Pereira, I. M. M., Figueredo, E. P. R., & Vasconcelos, A. S. de. (2023). Associação entre subtipos intrínsecos de câncer de mama e IMC elevado: revisão sistemática. Scire Salutis, 13(2), 113-125. https://doi.org/10.6008/cbpc2236-9600.2023.002.0010

Skrivankova, V. W., Richmond, R. C., Woolf, B. A. R., Yarmolinsky, J., Davies, N. M., Swanson, S. A., VanderWeele, T. J., Higgins, J. P. T., Timpson, N. J., Dimou, N., Langenberg, C., Golub, R. M., Loder, E. W., Gallo, V., Tybjaerg-Hansen, A., Davey Smith, G., Egger, M., & Richards, J. B. (2021). Strengthening the reporting of Observational Studies in Epidemiology using Mendelian randomization: The STROBE-MR Statement: The STROBE-MR statement. The Journal of the American Medical Association, 326(16), 1614-1621. https://doi.org/10.1001/jama.2021.18236

Stordal, B., Harvie, M., Antoniou, M. N., Bellingham, M., Chan, D. S. M., Darbre, P., Karlsson, O., Kortenkamp, A., Magee, P., Mandriota, S., Silva, E., Turner, J. E., Vandenberg, L. N., & Evans, D. G. (2024). Breast cancer risk and prevention in 2024: An overview from the Breast Cancer UK - Breast Cancer Prevention Conference. Cancer Medicine, 13(18), e70255. https://doi.org/10.1002/cam4.70255

Taroeno-Hariadi, K. W., Putra, Y. R., Ariesta, N. F., Sinorita, H., Hardianti, M. S., Widodo, I., & Aryandono, T. (2022). The association between abdominal obesity, metabolic syndrome and survival outcomes in patients with breast cancer. Asian Pacific Journal of Cancer Prevention: APJCP, 23(9), 3157-3165. https://doi.org/10.31557/APJCP.2022.23.9.3157

Thompson, C., Rahman, M. M., Singh, S., Arthur, S., Sierra-Bakhshi, C., Russell, R., Denning, K., Sundaram, U., & Salisbury, T. (2021). The adipose tissue-derived secretome (ADS) in obesity uniquely induces L-type amino acid transporter 1 (LAT1) and mTOR signaling in estrogen-receptor-positive breast cancer cells. International Journal of Molecular Sciences, 22(13), 6706. https://doi.org/10.3390/ijms22136706

Wang, W., Wang, X., Jiang, Y., Guo, Y., Fu, P., He, W., & Fu, X. (2025). Normal weight obesity, circulating biomarkers and risk of breast cancer: A prospective cohort study and meta-analysis. British Journal of Cancer, 132(2), 203-211. https://doi.org/10.1038/s41416-024-02906-1

Wiggs, A. G., Chandler, J. K., Aktas, A., Sumner, S. J., & Stewart, D. A. (2021). The effects of diet and exercise on endogenous estrogens and subsequent breast cancer risk in postmenopausal women. Frontiers in Endocrinology, 12, 732255. https://doi.org/10.3389/fendo.2021.732255

Ye, Z., Li, S., Dite, G. S., Nguyen, T. L., MacInnis, R. J., Andrulis, I. L., Buys, S. S., Daly, M. B., John, E. M., Kurian, A. W., Genkinger, J. M., Chung, W. K., Phillips, K. A., Thorne, H., Winship, I. M., Milne, R. L., Dugué, P. A., Southey, M. C., Giles, G. G., …, & Hopper, J. L. (2022). Weight is more informative than body mass index for predicting postmenopausal breast cancer risk: Prospective Family Study Cohort (ProF-SC). Cancer Prevention Research (Philadelphia, Pa.), 15(3), 185-191. https://doi.org/10.1158/1940-6207.CAPR-21-0164